Glimepiride
Back to searchMolecule Structure
Scientific Name
Glimepiride
Description of the Drug
Glimepiride is a sulfonylurea drug used to treat type 2 diabetes mellitus.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00222
http://www.drugbank.ca/drugs/DB00222
Brand Name(s)
Amaryl, Glimepiride, Niddaryl
Company Owner(s)
Takeda Pharmaceuticals Usa Inc, Invagen Pharmaceuticals Inc, Watson Laboratories Inc, Mylan Pharmaceuticals Inc, Prinston Pharmaceutical Inc, Sb Pharmco Puerto Rico Inc, Indoco Remedies Ltd, Micro Labs Ltd, Teva Pharmaceuticals Usa Inc, Accord Healthcare Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sulfonylurea receptor 1, Kir6.2 | PROTEIN COMPLEX | BLOCKER | CHEMBL2096972 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL16086 | |
| DrugBank | DB00222 | |
| PubChem: Thomson Pharma | 14908413 | |
| LINCS | LSM-44957 | |
| Nikkaji | J35.096F | |
| BindingDB | 50237590 | |
| EPA CompTox Dashboard | DTXSID5040675 | |
| DrugCentral | 1300 | |
| Brenda | 147756 | |
| ChemicalBook | CB8275358 | CB8318552 |
| Guide to Pharmacology | 6820 | |
| rxnorm | GLIMEPIRIDE | AMARYL |
| PubChem: Drugs of the Future | 12013623 | |
| ChEBI | 5383 | |
| ZINC | ZINC000100070954 |
